Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedRemoved the explicit reference to 'Prostate cancer' and the 'Related topics' section, including the 'MedlinePlus Genetics' link. This alters the page's disease context and access to a genetics resources section.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays a 500 error screen stating that the page is currently unavailable, replacing the study record content with a generic error message.SummaryDifference17%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new site revision tag (v3.6.4) replacing the previous v3.6.3, indicating a minor update to the site's backend or templates and no change to the study details.SummaryDifference0.1%

- Check53 days agoChange DetectedThe footer revision label updated from v3.6.2 to v3.6.3, signaling a minor site update to the page rendering without changing study information.SummaryDifference0.1%

- Check60 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, signaling a backend/UI version update.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now shows recruitment closed ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and updates the page revision to v3.6.0.SummaryDifference0.6%

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.